December 31 2019 2018 Change MB % MB % MB % Cost of sales 157.39 41.87 125.04 39.37 32.35 2.50 Selling expenses 106.75 28.40 101.32 31.90 5.43 3.50 Administrative expenses 49.98 13.30 50.26 15.83 (0.28
bonus forgone by an executive into other income of Baht 2.25 million. For the Year Ended December 31 2019 2018 Change MB % MB % MB % Cost of sales 157.39 41.87 125.04 39.37 32.35 2.50 Selling expenses
bonus forgone by an executive into other income of Baht 2.25 million. For the Year Ended December 31 2019 2018 Change MB % MB % MB % Cost of sales 157.39 41.87 125.04 39.37 32.35 2.50 Selling expenses
received from current investment. 2. Cost of sale , Profit margin In Q2/2017 the company had cost of sale Baht 82.97 million compare with the same period of previous year amount to Baht 68.01 million
100.64 98.55 15.89 15.79 Other main revenues 5.17 4.25 1.48 1.45 3.69 249.23 Total revenues from medical services 121.70 100.00 102.12 100.00 19.58 19.18 Cost of services (114.25) (93.87) (99.60) (97.53
) (75.17) Other income 6.52 2.57 4.61 0.46 15.04 5.74 8.10 0.81 1.91 41.43 Total income 253.31 100.00 998.59 100.00 261.83 100.00 1,002.08 100.00 (745.28) (74.63) Cost of real estate sales 149.05 60.40
2017 Change % Change Revenue 849.62 707.22 142.40 20% Cost 721.26 596.69 Gross profit 128.36 110.53 17.83 16% Gross profit margin 15.11% 15.63% Other income 0.24 3.80 (3.56) -94% Selling expenses 1.89
. Meanwhile, domestic branded sales slightly increased. Net loss in Q2/2018 was Baht 15 million, a decrease due to 1) a one-time cost of financial advisory fees and legal consultant fees of Baht 22 million
medical services 121.38 117.29 104.77 4.08 3.48 16.60 15.85 340.79 286.49 54.29 18.95 Cost of services 112.06 107.97 100.54 4.09 3.79 11.52 11.46 319.63 289.14 30.49 10.55 Gross profit (loss) 9.31 9.33 4.23
901.89 98.75 (742.61) (82.34) Other income 13.67 7.90 7.88 0.87 16.73 9.51 11.39 1.25 5.79 73.48 Total income 172.95 100.00 909.77 100.00 176.01 100.00 913.28 100.00 (736.82) (80.99) Cost of real estate